WV HB4263 | 2018 | Regular Session

Status

Spectrum: Bipartisan Bill
Status: Introduced on January 23 2018 - 25% progression
Action: 2018-01-23 - To House Prevention and Treatment of Substance Abuse
Pending: House Prevention and Treatment of Substance Abuse Committee
Text: Latest bill text (Introduced) [HTML]

Summary

The purpose of this bill is to reduce the number of opioids. It requires reports to licensing boards regarding abnormal prescribing practices; requires the Board of Pharmacy to report quarterly to various licensing boards; and permits the investigation and discipline for abnormal prescribing and dispensing of prescription drugs. The bill adds substances to Schedule I, II and IV of the Uniform Controlled Substances Act. And the bill allows licensing boards who regulate prescribers to investigate abnormal prescribing and dispensing of prescription drugs based upon information.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Reducing the use of opiates

Sponsors


History

DateChamberAction
2018-01-23HouseTo House Prevention and Treatment of Substance Abuse
2018-01-23HouseIntroduced in House
2018-01-23HouseTo Prevention and Treatment of Substance Abuse then Judiciary
2018-01-23HouseFiled for introduction

Same As/Similar To

SB273 (Similar To) 2018-04-23 - Chapter 46, Acts, Regular Session, 2018

Subjects


West Virginia State Sources


Bill Comments

feedback